TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $45

Astrana Health Inc.

Astrana Health Inc.

ASTH

0.00

TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ: ASTH) with a Buy and raises the price target from $35 to $45.